Unmet Needs Surrounding mCRC Treatment
Key opportunities to improve the mCRC treatment landscape are illustrated by the expert panelists.
Source: onclive.com
Stay updated with breaking news from Evolving Treatment. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Key opportunities to improve the mCRC treatment landscape are illustrated by the expert panelists.
The experts provide their final thoughts surrounding the impact of prospective trials and therapy regimens for treating patients with refractory mCRC.
Multiple abstracts from ESMO 2023, including a focus on tumor location, are highlighted.
Dr Kim offers key perspective for MSI-high patients based on data presented at ASCO 2024.
Key factors, particularly neuropathy, drive the discussion for platinum-based therapy for patients with non-refractory mCRC.